Johnson & Johnson CONTACTLENSESOTHER — Sales to customers (Note 9) increased by 5.5% to $2.04B in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 5.2%, from $1.94B to $2.04B. Over 2 years (FY 2021 to FY 2024), CONTACTLENSESOTHER — Sales to customers (Note 9) shows an upward trend with a 11.7% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates growing market share or higher consumer demand for vision care products, while a decrease may signal increased competition or a shift in consumer preferences.
This metric represents the total net revenue generated from the sale of contact lenses and associated vision care produc...
Comparable to revenue reported by other medical device or consumer health companies with dedicated vision care or optical business units.
jnj_segment_contact_lenses_other_sales_to_customers_note_9| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.71B | $1.74B | $1.76B | $1.68B | $1.82B | $1.79B | $1.82B | $1.91B | $1.86B | $1.82B | $1.84B | $1.94B | $1.87B | $1.84B | $1.93B | $2.04B |
| QoQ Change | — | +1.3% | +1.5% | -4.5% | +8.1% | -1.9% | +1.6% | +5.0% | -2.6% | -1.9% | +0.9% | +5.4% | -3.2% | -1.9% | +5.0% | +5.5% |
| YoY Change | — | — | — | — | +6.2% | +2.9% | +3.0% | +4.7% | +3.9% | — | -3.7% | +4.3% | — | +1.0% | +5.1% | +5.2% |
We use cookies for analytics. See our Privacy and Cookie Policy.